-
Mashup Score: 19Treg engineers take aim at autoimmunity - Nature Biotechnology - 3 year(s) ago
Companies are deploying regulatory T cells, equipped with CAR and TCR constructs, to suppress immunity—locally and for the long term.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 50Locus-specific expression of transposable elements in single cells with CELLO-seq - Nature Biotechnology - 3 year(s) ago
Expression of transposable elements is mapped to unique genomic loci with CELLO-seq.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 31Sparse deconvolution improves the resolution of live-cell super-resolution fluorescence microscopy - Nature Biotechnology - 3 year(s) ago
The resolution of fluorescence microscopy is increased by incorporating prior information into deconvolution algorithms.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 30Sensitive identification of neoantigens and cognate TCRs in human solid tumors - Nature Biotechnology - 3 year(s) ago
NeoScreen helps identify rare tumor antigens for personalized cancer vaccines and T cell therapies.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
RNA cargo is transferred into cultured cells using a fully human delivery system.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
Early results promise a one-off treatment, but gene-editing and gene therapies will have to show durable protection and be affordable to the many patients with sickle cell disease in the world.
Source: Nature BiotechnologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 13
Early results promise a one-off treatment, but gene-editing and gene therapies will have to show durable protection and be affordable to the many patients with sickle cell disease in the world.
Source: Nature BiotechnologyCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 5
Early results promise a one-off treatment, but gene-editing and gene therapies will have to show durable protection and be affordable to the many patients with sickle cell disease in the world.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 26A fluorescent sensor for spatiotemporally resolved imaging of endocannabinoid dynamics in vivo - Nature Biotechnology - 3 year(s) ago
A genetically encoded sensor reveals the dynamics of endocannabinoid signaling.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 30How biomanufacturing can save the world - Nature Biotechnology - 3 year(s) ago
With supply-chain shortages and production problems exacerbating vaccine inequity, global manufacturing must expand to ensure the world’s poorest nations are better served.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
Engineered adoptive T-cell therapies have already transformed the treatment of blood cancers. Startups hope to harness the power of Treg cells to suppress immune responses for transplant recipients, or to control inflammation driving autoimmune disorders https://t.co/ME97UkZVIV https://t.co/24TR08ImS7